Asthma Clinical Trials

ctgov trial 2

    dddd

Formal Build 2 V4.1

Test Campaign Performance Report  

Test Campaign Performance Report

Test CPR 2  

Test CPR 2

Evaluation of AZD8154 Concentrations in Blood

This study is intended to evaluate the systemic pharmacokinetic (PK) characteristics and the safety of AZD8154 following administration of the Monodose DPI formulation compared with the administration of the nebuliser suspension.

Sapiens_Val

Val_ainfo.io (formal)

Characterisation of the Nasal Microbiome in Patients With N-ERD

It may also be associated with a hypersensitivity to non-steroidal anti-inflammatory (NSAID) drugs in a syndrome called NSAID-exacerbated respiratory disease (N-ERD) characterized by highly recurrent polyps and concomitant asthma. The pathophysiological mechanisms especially with regards to the potential role of the microbiome in driving N-ERD are so far not fully …

Sandeep 03821 testing  

Testing by Sandeep 

Early Environmental and Maternal Determinants of Airway Inflammation in Wheezing Disorders in Infants

This study collects data on microbiological, genetic and environmental factors, as well as lung function parameters (e.g. spirometry, body plethysmography, lung-MRI) to assess the complex interaction of predisposing risk factors for impaired lung development and respiratory diseases.

Registry of Asthma Patients Initiating DUPIXENT

The primary objective of the study is to characterize the patients who initiate treatment for asthma with DUPIXENT in a real-world setting. The secondary objectives of the study are: To characterize real-world use patterns of DUPIXENT for asthma To assess the long-term effectiveness of DUPIXENT in asthma patients in a …